Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction

The aim of the study was to assess if cardiovascular disease-associated microRNAs would be able to predict during the early stages of gestation (within 10 to 13 weeks) subsequent onset of hypertensive pregnancy-related complications: gestational hypertension (GH) or preeclampsia (PE). Secondly, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hromadnikova, Ilona, Kotlabova, Katerina, Krofta, Ladislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869238/
https://www.ncbi.nlm.nih.gov/pubmed/35203467
http://dx.doi.org/10.3390/biomedicines10020256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869238/
https://www.ncbi.nlm.nih.gov/pubmed/35203467
http://dx.doi.org/10.3390/biomedicines10020256

Ejemplares similares